[go: up one dir, main page]

HK40064531B - Therapeutic solid dosage forms - Google Patents

Therapeutic solid dosage forms Download PDF

Info

Publication number
HK40064531B
HK40064531B HK42022053653.6A HK42022053653A HK40064531B HK 40064531 B HK40064531 B HK 40064531B HK 42022053653 A HK42022053653 A HK 42022053653A HK 40064531 B HK40064531 B HK 40064531B
Authority
HK
Hong Kong
Prior art keywords
dosage forms
solid dosage
therapeutic solid
therapeutic
forms
Prior art date
Application number
HK42022053653.6A
Other languages
Chinese (zh)
Other versions
HK40064531A (en
Inventor
Rands Peter
Benway Tiffanie
Joel Zelah
Layzell Marie
James Ellen
Original Assignee
Cybin Uk Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cybin Uk Ltd filed Critical Cybin Uk Ltd
Publication of HK40064531A publication Critical patent/HK40064531A/en
Publication of HK40064531B publication Critical patent/HK40064531B/en

Links

HK42022053653.6A 2020-06-02 2022-05-17 Therapeutic solid dosage forms HK40064531B (en)

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
WOPCT/EP2020/065244 2020-06-02
GB2008303 2020-06-02
US16890664 2020-06-02
GB2018950 2020-12-01
GB2018955 2020-12-01
US17108938 2020-12-01
US17108679 2020-12-01
US17208583 2021-03-22
GB2103981 2021-03-22
WOPCT/EP2021/060750 2021-04-23

Publications (2)

Publication Number Publication Date
HK40064531A HK40064531A (en) 2022-07-08
HK40064531B true HK40064531B (en) 2023-10-20

Family

ID=

Similar Documents

Publication Publication Date Title
EP4149460B8 (en) Therapeutic solid dosage forms
EP4238556A4 (en) Gastroretentive pharmaceutical dosage form
EP3893993A4 (en) Internal ultraviolet therapy
EP4004017A4 (en) Platelet-facilitated delivery of therapeutic compounds
HK40120570A (en) Therapeutic solid dosage forms
HK40064531B (en) Therapeutic solid dosage forms
EP4052699A4 (en) Orally administered solid dosage form drug
EP3982937A4 (en) Pharmaceutical formulations containing gaboxadol for therapeutic treatment
AU2022297426A1 (en) Therapeutic compounds
HK40107495A (en) Dosage regime
HK40082055A (en) Therapeutic compounds
HK40093467A (en) Acalabrutinib maleate dosage forms
HK40108760A (en) Therapeutic derivatives of interleukin-22
HK40090884A (en) Gastroretentive pharmaceutical dosage form
IL323748A (en) Dosage
HK40105578A (en) Therapeutic methods
HK40111417A (en) Therapeutic conjugate
AU2021904036A0 (en) Solid dosage forms for aquaculture
HK40101542A (en) Combination therapy
GB202203093D0 (en) Medicament
AU2024306538A1 (en) Combination therapy
AU2023900945A0 (en) Combination therapeutic formulation
HK40090526A (en) Combination therapy
HK40093374A (en) Cobitolimod dosage for self-administration
AU2023902987A0 (en) Combination therapy